bioAffinity Technologies, Inc. (BIAF)
9.93
-0.57
(-5.43%)
USD |
NASDAQ |
Sep 10, 13:28
bioAffinity Technologies Total Liabilities (Quarterly) : 3.850M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.850M |
| March 31, 2026 | 4.284M |
| December 31, 2025 | 3.683M |
| September 30, 2025 | 2.644M |
| June 30, 2025 | 6.887M |
| March 31, 2025 | 4.108M |
| December 31, 2024 | 3.912M |
| September 30, 2024 | 3.431M |
| June 30, 2024 | 3.223M |
| March 31, 2024 | 2.792M |
| December 31, 2023 | 3.366M |
| September 30, 2023 | 3.196M |
| Date | Value |
|---|---|
| June 30, 2023 | 0.7752M |
| March 31, 2023 | 0.7963M |
| December 31, 2022 | 1.139M |
| September 30, 2022 | 1.464M |
| June 30, 2022 | 13.68M |
| March 31, 2022 | 14.03M |
| December 31, 2021 | 13.20M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 11.17M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 46.19M |
| Perspective Therapeutics, Inc. | 68.16M |
| MiMedx Group, Inc. | 65.00M |
| Veracyte, Inc. | 97.96M |
| ABVC BioPharma, Inc. | 7.131M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.619M |
| Shareholders Equity (Quarterly) | 3.769M |
| Debt to Equity Ratio | 0.3808 |
| Current Ratio | 1.442 |
| Net Debt Paydown Yield | -0.38% |